« Return to News | CROs/Service Providers

Premier’s Management Makes Preliminary Bid for Company

Wednesday, August 29, 2007 02:22 PM

Some of Premier Research Group’s top management made a preliminary approach to its board, exploring an offer to buy the contract research organization (CRO), according to Thomson Financial.

London-based Premier said that there can be no guarantee that this initial approach will lead to an offer being made for the company.

Premier has been on acquisition spree by buying six CROs since it went public in London in 2004. In July, the company purchased its latest two CROs. Premier bought ARS Inc., based in Boston, and D-TARGET SA, located in Switzerland.

Premier expects ARS will strengthen its presence in the New England biotech market while D-Target's medical device focus will bring expanded expertise in that area to customers in the United States and Europe. The acquisitions continue Premier’s strategy of building an international business both organically and through strategic acquisitions.

Since January, Premier’s shares in London have fallen significantly, but closed up 13.6% on August 29.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.